Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Owen Williams, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE, Rockhold FW, Broderick S, Ferguson TB, Williams DO, Harrington RA, Stone GW, Rosenberg Y. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020 04 09; 382(15):1395-1407. PMID: 32227755.
    Citations:    
  2. Williams DO, Shah PB. When Revascularization Needs to Be Repeated for Left Main Disease. JACC Cardiovasc Interv. 2020 02 10; 13(3):388-390. PMID: 31954678.
    Citations:    
  3. Faxon DP, Leopold JA, Abbott JD, McElhinney DB, Williams DO. Circulation: Cardiovascular Interventions: The First 10 Years. Circ Cardiovasc Interv. 2018 06; 11(6):e006901. PMID: 29895606.
    Citations:    Fields:    
  4. Carreras ET, Williams DO. Interventional Cardiology: The In and the Out. Circ Cardiovasc Interv. 2018 04; 11(4):e006709. PMID: 29654120.
    Citations:    Fields:    
  5. Ng AK, Shah PB, Williams DO. Percutaneous Revascularization of Chronic Total Coronary Occlusion: For Whom? Circ Cardiovasc Interv. 2017 06; 10(6). PMID: 28615235.
    Citations: 1     Fields:    
  6. Faxon DP, Williams DO. Interventional Cardiology: Current Status and Future Directions in Coronary Disease and Valvular Heart Disease. Circulation. 2016 Jun 21; 133(25):2697-711. PMID: 27324364.
    Citations: 2     Fields:    Translation:HumansAnimals
  7. Williams DO, Sobieszczyk P. Coronary Brachytherapy 2016. JACC Cardiovasc Interv. 2016 06 27; 9(12):1266-8. PMID: 27339843.
    Citations:    Fields:    Translation:Humans
  8. Chau CH, Williams DO. Prevention of Contrast-Induced Renal Failure for the Interventional Cardiologist. Circ Cardiovasc Interv. 2016 06; 9(6). PMID: 27313283.
    Citations:    Fields:    Translation:Humans
  9. Stone GW, Hochman JS, Williams DO, Boden WE, Ferguson TB, Harrington RA, Maron DJ. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise. J Am Coll Cardiol. 2016 Jan 05; 67(1):81-99. PMID: 26616030.
    Citations: 9     Fields:    Translation:Humans
  10. Wimmer NJ, Williams DO. Transcatheter aortic valve replacement and stroke. Circ Cardiovasc Interv. 2015 Jun; 8(6). PMID: 26043896.
    Citations: 1     Fields:    Translation:Humans
  11. Williams DO. Cardiac surgery with percutaneous interventional backup: a paradigm shift. Circ Cardiovasc Interv. 2014 Jun; 7(3):275-7. PMID: 24944300.
    Citations:    Fields:    Translation:Humans
  12. Chan CY, Vlachos H, Selzer F, Mulukutla SR, Marroquin OC, Abbott DJ, Holper EM, Williams DO. Comparison of drug-eluting and bare metal stents in large coronary arteries: findings from the NHLBI dynamic registry. Catheter Cardiovasc Interv. 2014 Jul 01; 84(1):24-9. PMID: 24323698.
    Citations: 3     Fields:    Translation:Humans
  13. Chan P, Williams DO. Coronary revascularization for myocardial ischemia. Circ Cardiovasc Interv. 2013 Apr; 6(2):123-4. PMID: 23591417.
    Citations:    Fields:    Translation:Humans
  14. Vasaiwala S, Williams DO. Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials. Curr Cardiol Rep. 2012 Aug; 14(4):468-76. PMID: 22638907.
    Citations:    Fields:    Translation:Humans
  15. Vasaiwala S, Vlachos H, Selzer F, Marroquin O, Mulukutla S, Abbott JD, Williams DO. Comparison of bare-metal stents and drug-eluting stents in coronary ostial lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2012 Oct 15; 110(8):1113-8. PMID: 22762712.
    Citations:    Fields:    Translation:Humans
  16. Faxon DP, Williams DO. The changing face of interventional cardiology. Circ Cardiovasc Interv. 2012 Jun; 5(3):325-7. PMID: 22715447.
    Citations: 2     Fields:    Translation:Humans
  17. Kaplan AV, Williams DO. Medical device regulatory landscape: the imperative of finding balance. Circ Cardiovasc Interv. 2012 Feb 01; 5(1):2-5. PMID: 22337999.
    Citations: 1     Fields:    Translation:HumansAnimalsPHPublic Health
  18. Leitner J, Vlachos HA, Selzer F, Jamal SM, Kip KE, Williams DO, Abbott JD. Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry). Am J Cardiol. 2012 Feb 15; 109(4):466-70. PMID: 22118825.
    Citations:    Fields:    Translation:Humans
  19. Bangalore S, Vlachos HA, Selzer F, Wilensky RL, Kip KE, Williams DO, Faxon DP. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2011 Jan 01; 77(1):22-8. PMID: 20506328.
    Citations: 12     Fields:    Translation:Humans
  20. Williams DO, Vasaiwala SC, Boden WE. Is optimal medical therapy "optimal therapy" for multivessel coronary artery disease? Optimal management of multivessel coronary artery disease. Circulation. 2010 Sep 07; 122(10):943-5. PMID: 20733095.
    Citations: 1     Fields:    Translation:Humans
  21. Wolf WM, Vlachos HA, Marroquin OC, Lee JS, Smith C, Anderson WD, Schindler JT, Holper EM, Abbott JD, Williams DO, Laskey WK, Kip KE, Kelsey SF, Mulukutla SR. Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv. 2010 Feb 01; 3(1):42-9. PMID: 20118153.
    Citations: 2     Fields:    Translation:Humans
  22. Williams DO, Abbott JD. Diabetes mellitus does not unsweeten left main intervention. JACC Cardiovasc Interv. 2009 Oct; 2(10):964-6. PMID: 19850256.
    Citations:    Fields:    Translation:Humans
  23. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv. 2009 Jul; 2(7):594-600. PMID: 19628179.
    Citations: 60     Fields:    Translation:HumansCTClinical Trials
  24. Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF. Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries. Circ Cardiovasc Interv. 2009 Feb; 2(1):6-13. PMID: 20031687.
    Citations: 16     Fields:    Translation:Humans
  25. Maksimowicz-McKinnon K, Selzer F, Manzi S, Kip KE, Mulukutla SR, Marroquin OC, Smitherman TC, Kuller LH, Williams DO, Wasko MC. Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv. 2008 Dec; 1(3):201-8. PMID: 20031679.
    Citations: 8     Fields:    Translation:Humans
  26. Chevalier B, Di Mario C, Neumann FJ, Ribichini F, Urban P, Popma JJ, Fitzgerald PJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Schwartz LB. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. JACC Cardiovasc Interv. 2008 Oct; 1(5):524-32. PMID: 19463354.
    Citations: 5     Fields:    Translation:Humans
  27. Holmes DR, Williams DO. Catheter-based treatment of coronary artery disease: past, present, and future. Circ Cardiovasc Interv. 2008 Aug; 1(1):60-73. PMID: 20031656.
    Citations: 5     Fields:    Translation:Humans
  28. Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC Cardiovasc Interv. 2008 Apr; 1(2):139-47. PMID: 19212456.
    Citations: 5     Fields:    Translation:Humans
  29. Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008 Jan 24; 358(4):342-52. PMID: 18216354.
    Citations: 34     Fields:    Translation:Humans
  30. Williams DO, Abbott JD. Bifurcation intervention: is it crush time yet? J Am Coll Cardiol. 2005 Aug 16; 46(4):621-4. PMID: 16098425.
    Citations:    Fields:    Translation:Humans
  31. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 02; 349(14):1315-23. PMID: 14523139.
    Citations: 500     Fields:    Translation:HumansCTClinical Trials
  32. Srinivas VS, Brooks MM, Detre KM, King SB, Jacobs AK, Johnston J, Williams DO. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study. Circulation. 2002 Sep 24; 106(13):1627-33. PMID: 12270854.
    Citations: 17     Fields:    Translation:Humans
  33. Williams DO. Intracoronary brachytherapy: past, present, and future. Circulation. 2002 Jun 11; 105(23):2699-700. PMID: 12057979.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Williams's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (134)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.